Literature DB >> 22895174

Dephosphorylation of threonine-821 of the retinoblastoma tumor suppressor protein (Rb) is required for apoptosis induced by UV and Cdk inhibition.

Brandon Lentine1, Lisa Antonucci, Ray Hunce, Justina Edwards, Valerie Marallano, Nancy A Krucher.   

Abstract

The Retinoblastoma protein (Rb) is important in the control of cell proliferation and apoptosis. Its activity is controlled by reversible phosphorylation on several serine and threonine residues. When Rb is hypophosphorylated, it inhibits proliferation by preventing passage through the G 1- S phase transition. Hyperphosphorylated Rb promotes cell cycle progression. The role of Rb phosphorylation in the control of apoptosis is largely unknown, although several apoptotic stimuli result in dephosphorylation of Rb. It may be that dephosphorylation of specific amino acids signals apoptosis vs. cell cycle arrest. Using glutamic acid mutagenesis, we have generated 15 single phosphorylation site mutants of Rb to alter serine/threonine to glutamic acid to mimic the phosphorylated state. By calcium phosphate transfection, mutant plasmids were introduced into C33A Rb-null cells, and apoptosis was induced using UV. Apoptosis was measured by ELISA detection of degraded DNA and by immunoblotting to assess proteolytic cleavage of PARP. Our results show that only mutation of threonine-821 to glutamic acid (T821E) blocked apoptosis by 50%, whereas other sites tested had little effect. In Rb-null Saos-2 and SKUT-1 cells, the T821E mutation also blocked apoptosis induced by the cdk inhibitor, Roscovitine, by 50%. In addition, we show that endogenous Rb is dephosphorylated on threonine-821 when cells are undergoing apoptosis. Thus, our data indicates that dephosphorylation of threonine-821 of Rb is required for cells to undergo apoptosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895174      PMCID: PMC3466530          DOI: 10.4161/cc.21693

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  48 in total

1.  Site-specific and temporally-regulated retinoblastoma protein dephosphorylation by protein phosphatase type 1.

Authors:  E Rubin; S Mittnacht; E Villa-Moruzzi; J W Ludlow
Journal:  Oncogene       Date:  2001-06-28       Impact factor: 9.867

2.  SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells.

Authors:  Hyo-Sung Jeon; Tatiana Dracheva; Sei-Hoon Yang; Daoud Meerzaman; Junya Fukuoka; Abbas Shakoori; Konstantin Shilo; William D Travis; Jin Jen
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

3.  High molecular weight protein phosphatase type 1 dephosphorylates the retinoblastoma protein.

Authors:  D A Nelson; N A Krucher; J W Ludlow
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

4.  Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.

Authors:  David E MacCallum; Jean Melville; Sheelagh Frame; Kathryn Watt; Sian Anderson; Athos Gianella-Borradori; David P Lane; Simon R Green
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

5.  RB-dependent S-phase response to DNA damage.

Authors:  K E Knudsen; D Booth; S Naderi; Z Sever-Chroneos; A F Fribourg; I C Hunton; J R Feramisco; J Y Wang; E S Knudsen
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

6.  Multiple pathways counteract cell death induced by RB1 loss: implications for cancer.

Authors:  Giovanni Ciavarra; Eldad Zacksenhaus
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

7.  Glutamic acid mutagenesis of retinoblastoma protein phosphorylation sites has diverse effects on function.

Authors:  S Barrientes; C Cooke; D W Goodrich
Journal:  Oncogene       Date:  2000-01-27       Impact factor: 9.867

8.  Blockade of tumor necrosis factor-induced Bid cleavage by caspase-resistant Rb.

Authors:  XiaoDong Huang; Anja Masselli; Steven M Frisch; Irina C Hunton; Yong Jiang; Jean Y J Wang
Journal:  J Biol Chem       Date:  2007-08-08       Impact factor: 5.157

9.  Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis.

Authors:  R Agami; G Blandino; M Oren; Y Shaul
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

10.  Inhibition of apoptosis by the retinoblastoma gene product.

Authors:  D A Haas-Kogan; S C Kogan; D Levi; P Dazin; A T'Ang; Y K Fung; M A Israel
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more
  12 in total

1.  A Code of Mono-phosphorylation Modulates the Function of RB.

Authors:  Ioannis Sanidas; Robert Morris; Katerina A Fella; Purva H Rumde; Myriam Boukhali; Eric C Tai; David T Ting; Michael S Lawrence; Wilhelm Haas; Nicholas J Dyson
Journal:  Mol Cell       Date:  2019-01-30       Impact factor: 17.970

2.  A System-wide Approach to Monitor Responses to Synergistic BRAF and EGFR Inhibition in Colorectal Cancer Cells.

Authors:  Anna Ressa; Evert Bosdriesz; Joep de Ligt; Sara Mainardi; Gianluca Maddalo; Anirudh Prahallad; Myrthe Jager; Lisanne de la Fonteijne; Martin Fitzpatrick; Stijn Groten; A F Maarten Altelaar; René Bernards; Edwin Cuppen; Lodewyk Wessels; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2018-07-03       Impact factor: 5.911

Review 3.  Post-translational modifications on the retinoblastoma protein.

Authors:  Linbin Zhou; Danny Siu-Chun Ng; Jason C Yam; Li Jia Chen; Clement C Tham; Chi Pui Pang; Wai Kit Chu
Journal:  J Biomed Sci       Date:  2022-06-01       Impact factor: 12.771

4.  Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4-pRB Axis in Fibroblasts at the Invasive Tumor Edge.

Authors:  Gina Bouchard; Fernando Jose Garcia-Marques; Loukia Georgiou Karacosta; Weiruo Zhang; Abel Bermudez; Nicholas McIlvain Riley; Sushama Varma; Lindsey Catherine Mehl; Jalen Anthony Benson; Joseph B Shrager; Carolyn Ruth Bertozzi; Sharon J Pitteri; Amato J Giaccia; Sylvia Katina Plevritis
Journal:  Cancer Res       Date:  2022-02-15       Impact factor: 13.312

Review 5.  Deciphering the retinoblastoma protein phosphorylation code.

Authors:  Seth M Rubin
Journal:  Trends Biochem Sci       Date:  2012-12-03       Impact factor: 13.807

6.  The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness.

Authors:  Ettickan Boopathi; Steve Ciment; Chellappagounder Thangavel; Yi Liu; Raymond O'Neill; Ankur Sharma; Steve B McMahon; Hestia Mellert; Sankar Addya; Adam Ertel; Ruth Birbe; Paolo Fortina; Adam P Dicker; Karen E Knudsen; Robert B Den
Journal:  Clin Cancer Res       Date:  2014-08-27       Impact factor: 12.531

Review 7.  RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy.

Authors:  Paola Indovina; Francesca Pentimalli; Nadia Casini; Immacolata Vocca; Antonio Giordano
Journal:  Oncotarget       Date:  2015-07-20

8.  Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb.

Authors:  Jacklynn V Egger; Maria V Lane; Lisa A Antonucci; Brixhilda Dedi; Nancy A Krucher
Journal:  Cancer Biol Ther       Date:  2016-09-19       Impact factor: 4.742

9.  Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer.

Authors:  Sheelagh Frame; Chiara Saladino; Craig MacKay; Butrus Atrash; Peter Sheldrake; Edward McDonald; Paul A Clarke; Paul Workman; David Blake; Daniella Zheleva
Journal:  PLoS One       Date:  2020-07-09       Impact factor: 3.240

10.  Phosphorylation of the Retinoblastoma protein (Rb) on serine-807 is required for association with Bax.

Authors:  Lisa A Antonucci; Jacklynn V Egger; Nancy A Krucher
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.